Resources

Type of publications
Regions
Diseases

5192 results found

2021 ∙ Heidari, S. Palmer-Ross, A. Goodman, T.

A systematic review of the sex and gender reporting in covid-19 clinical trials

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Khandker, S. S. Godman, B. Jawad, M. I. Meghla, B. A. Tisha, T. A. Khondoker, M. U. Haq, M. A. Charan, J. Talukder, A. A. Azmuda, N. Sharmin, S. Jamiruddin, M. R. Haque, M. Adnan, N.

A systematic review on covid‐19 vaccine strategies, their effectiveness, and issues

  • All age groups
  • COVID-19
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Eze, P. Agu, S. A. Agu, U. J. Acharya, Y.

Acceptability of mobile-phone reminders for routine childhood vaccination appointments in Nigeria - a systematic review and meta-analysis

  • Africa
  • Nigeria
  • Adults
  • Parents/caregivers
  • Low and Middle Income Countries
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Nindrea, Ricvan Dana Usman, Elly Katar, Yusticia Sari, Nissa Prima

Acceptance of COVID-19 vaccination and correlated variables among global populations: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Aye, Y. N. Mai, A. S. Zhang, A. Lim, O. Z. H. Lin, N. Ng, C. H. Chan, M. Y. Yip, J. Loh, P. H. Chew, N. W. S.

Acute Myocardial Infarction and Myocarditis following COVID-19 Vaccination

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Di Donato, V. Caruso, G. Petrillo, M. Kontopantelis, E. Palaia, I. Perniola, G. Plotti, F. Angioli, R. Muzii, L. Panici, P. B. Bogani, G.

Adjuvant hpv vaccination to prevent recurrent cervical dysplasia after surgical treatment: A meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Amanzio, Martina Mitsikostas, Dimos D. Giovannelli, Fabio Bartoli, Massimo Cipriani, Giuseppina Elena Brown, Walter A.

Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Kaur, R. J. Dutta, S. Bhardwaj, P. Charan, J. Dhingra, S. Mitra, P. Singh, K. Yadav, D. Sharma, P. Misra, S.

Adverse Events Reported From  COVID-19 Vaccine Trials: A Systematic Review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Alhumaid, S. Al Mutair, A. Al Alawi, Z. Rabaan, A. A. Tirupathi, R. Alomari, M. A. Alshakhes, A. S. Alshawi, A. M. Ahmed, G. Y. Almusabeh, H. M. Alghareeb, T. T. Alghuwainem, A. A. Alsulaiman, Z. A. Alabdulmuhsin, M. A. AlBuwaidi, E. A. Dukhi, A. K. B. Mufti, H. N. Al-Qahtani, M. Dhama, K. Al-Tawfiq, J. A. Al-Omari, A.

Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Gagelmann, N. Passamonti, F. Wolschke, C. Massoud, R. Niederwieser, C. Adjallé, R. Mora, B. Ayuk, F. Kröger, N.

Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
Loading...